2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 26.792 | 40.037 | 72.367 | 105.125 | 223.398 | 491.059 | 539.599 | 645.412 | 714.919 |
Total Income - EUR | - | 26.792 | 40.037 | 72.367 | 105.125 | 223.398 | 491.059 | 539.718 | 645.414 | 714.923 |
Total Expenses - EUR | - | 31.803 | 39.807 | 64.393 | 113.164 | 191.685 | 419.887 | 458.945 | 572.240 | 654.148 |
Gross Profit/Loss - EUR | - | -5.011 | 230 | 7.973 | -8.038 | 31.713 | 71.172 | 80.773 | 73.173 | 60.775 |
Net Profit/Loss - EUR | - | -5.814 | -171 | 7.250 | -9.089 | 29.479 | 67.215 | 75.809 | 66.719 | 53.432 |
Employees | - | 2 | 2 | 3 | 3 | 5 | 6 | 0 | 7 | 8 |
Check the financial reports for the company - Eveniment Pharma Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 27.892 | 20.951 | 44.763 |
Current Assets | - | 10.316 | 10.013 | 35.882 | 34.744 | 78.806 | 190.641 | 191.690 | 213.203 | 204.828 |
Inventories | - | 5.139 | 7.177 | 22.901 | 23.763 | 34.988 | 70.865 | 74.425 | 85.025 | 82.350 |
Receivables | - | 4.631 | 2.493 | 12.530 | 9.853 | 30.590 | 47.755 | 59.235 | 65.657 | 84.296 |
Cash | - | 546 | 344 | 451 | 1.127 | 13.228 | 72.022 | 58.029 | 62.521 | 38.183 |
Shareholders Funds | - | -5.769 | -5.881 | 44 | -9.046 | 20.608 | 67.265 | 75.858 | 66.768 | 53.480 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 16.085 | 15.894 | 35.838 | 43.790 | 58.199 | 123.376 | 143.724 | 167.386 | 196.112 |
Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Eveniment Pharma Srl